Literature DB >> 3390072

Evolution of recruitment at different frequencies during the development of endolymphatic hydrops in the guinea pig.

K C Horner1, Y Cazals.   

Abstract

The study of human temporal bones has identified endolymphatic hydrops as a common feature of several diseases. In particular it is systematically found in those bones removed from patients with premortem Menière's disease. Menière's disease is known to induce sensorineural pathology with recruitment, which changes with the evolution of the hearing loss, and is suspected to induce a cochlear conductive loss by a possible increase in static pressure of endolymph. Amplitude/intensity functions of sensorineural responses can reflect recruitment and/or conduction loss. Experimentally induced hydrops in animals provokes cochlear physiological alterations, some of which closely resemble certain features of Menière's disease. In the present study using a guinea-pig animal model, we have examined amplitude/intensity functions at the round window for cochlear microphonics (RWCM), summating potentials (RWSP) and action potentials (CAP) at different stages of hearing loss in experimentally induced hydrops. During the period of fluctuating thresholds there was reduction of maximal RWCM amplitude, no change in RWSP and recruitment on the CAP. At a later stage when the audiogram was flat and fluctuations were no longer seen, RWCM remained unchanged. At this time RWSP could show recruitment while CAP amplitudes at all intensities were reduced, indicating either a cochlear conductive loss and/or a general depression of neural activity.

Entities:  

Mesh:

Year:  1988        PMID: 3390072     DOI: 10.1007/bf00481445

Source DB:  PubMed          Journal:  Arch Otorhinolaryngol        ISSN: 0302-9530


  22 in total

1.  Compound action potential (AP) tuning curves.

Authors:  P Dallos; M A Cheatham
Journal:  J Acoust Soc Am       Date:  1976-03       Impact factor: 1.840

2.  The salt loading provocative glycerol test for the early diagnosis of auditory endolymphatic hydrops (Ménière's disease) (a preliminary report).

Authors:  I K Arenberg; M H Stroud; G J Spector; W F Carver
Journal:  Rev Laryngol Otol Rhinol (Bord)       Date:  1974 Nov-Dec

3.  Neurophysiologic assessment of endolymphatic hydrops.

Authors:  T Morizono; M A Sikora
Journal:  Ann Otol Rhinol Laryngol       Date:  1984 May-Jun       Impact factor: 1.547

4.  Diagnostic significance of transtympanic electrocochleography in Menière's disease.

Authors:  W P Gibson; D K Prasher; G P Kilkenny
Journal:  Ann Otol Rhinol Laryngol       Date:  1983 Mar-Apr       Impact factor: 1.547

5.  Changes of the action potential, the summating potential and cochlear microphonics in experimental endolymphatic hydrops.

Authors:  H Kumagami; H Nishida; H Moriuchi
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  1981       Impact factor: 1.538

6.  Ménière's disease and the summating potential. III. Effect of glycerol administration.

Authors:  A C Coats; B R Alford
Journal:  Arch Otolaryngol       Date:  1981-08

7.  Atrophy of middle and short stereocilia on outer hair cells of guinea pig cochleas with experimentally induced hydrops.

Authors:  K C Horner; A Guilhaume; Y Cazals
Journal:  Hear Res       Date:  1988-01       Impact factor: 3.208

8.  Temporary loss of hearing after a glycerin test.

Authors:  D E Mattox; R L Goode
Journal:  Arch Otolaryngol       Date:  1978-06

9.  Summating potential and water balance in Meniere's disease.

Authors:  R Dauman; J M Aran; M Portmann
Journal:  Ann Otol Rhinol Laryngol       Date:  1986 Jul-Aug       Impact factor: 1.547

10.  Functional and morphological changes in experimental endolymphatic hydrops.

Authors:  J M Aran; K E Rarey; J E Hawkins
Journal:  Acta Otolaryngol       Date:  1984 May-Jun       Impact factor: 1.494

View more
  1 in total

1.  Speech Recognition During Follow-Up of Patients with Ménière's Disease: What Are We Missing?

Authors:  Octavio Garaycochea; Raquel Manrique-Huarte; Diego Calavia; Laura Girón; Nicolás Pérez-Fernández
Journal:  J Int Adv Otol       Date:  2022-01       Impact factor: 1.316

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.